KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mannkind (MNKD) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Mannkind (MNKD) over the last 11 years, with Q3 2025 value amounting to $4.5 million.

  • Mannkind's Cost of Revenue rose 4069.44% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.7 million, marking a year-over-year increase of 34327.19%. This contributed to the annual value of $17.4 million for FY2024, which is 1645.98% down from last year.
  • As of Q3 2025, Mannkind's Cost of Revenue stood at $4.5 million, which was up 4069.44% from $4.6 million recorded in Q2 2025.
  • Mannkind's 5-year Cost of Revenue high stood at $33.0 million for Q4 2021, and its period low was -$26.1 million during Q4 2022.
  • Moreover, its 5-year median value for Cost of Revenue was $4.6 million (2025), whereas its average is $5.9 million.
  • Data for Mannkind's Cost of Revenue shows a peak YoY increase of 25973.7% (in 2022) and a maximum YoY decrease of 17921.79% (in 2022) over the last 5 years.
  • Mannkind's Cost of Revenue (Quarter) stood at $33.0 million in 2021, then tumbled by 179.22% to -$26.1 million in 2022, then grew by 23.9% to -$19.9 million in 2023, then skyrocketed by 124.17% to $4.8 million in 2024, then decreased by 6.45% to $4.5 million in 2025.
  • Its Cost of Revenue stands at $4.5 million for Q3 2025, versus $4.6 million for Q2 2025 and $3.8 million for Q1 2025.